慢性肝病患者Fibrotouch检测与人口学特征关系的流行病学分析

肝脏 ›› 2016, Vol. 21 ›› Issue (7): 539-541.

慢性肝病患者Fibrotouch检测与人口学特征关系的流行病学分析

叶佩燕, 陆云飞, 陈晓蓉, 杨宗国

201508 上海上海市公共卫生临床中心

收稿日期:2016-04-15 出版日期:2016-07-31 发布日期:2020-07-09
通讯作者: 陈晓蓉,Email:xiaorong3chen@163.com

Epidemiology analysis of relationship between Fibrotouch tests and demographic features in chronic hepatopathy patients

YE Pei-yan, LU Yun-fei, CHEN Xiao-rong, YANG Zong-guo

Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China

Received:2016-04-15 Online:2016-07-31 Published:2020-07-09
Contact: CHEN Xiao-rong, Email: xiaorong3chen@163.com

摘要/Abstract

摘要： 目的评价慢性肝病患者Fibrotouch检测与人口学特征的相关性。方法收集慢性肝病患者性别、年龄、体质指数(BMI)及Fibrotouch相关参数并进行统计分析。结果女性肝硬度值及脂肪衰减相对降低(P均<0.001);随着年龄增长,肝硬度值逐渐升高(P<0.001);年龄、BMI及脂肪衰减参数与肝硬度值呈正相关,Spearman’s相关系数分别为0.301、0.187、0.107(P均<0.001)。而年龄、BMI与脂肪衰减参数正相关,Spearman’s相关系数分别为0.121,0.695(P均<0.001)。结论年龄、性别、BMI与Fibrotouch检测结果相关,对Fibrotouch诊断报告的阅读具有一定的参考价值。

关键词: 慢性肝病, 瞬时弹性超声, 体质指数, 年龄, 性别, 流行病学分析

Abstract: Objective To analyze the relationship between Fibrotouch tests and demographic features in chronic liver diseases.Methods Demographic features of chronic hepatopathy patients, including gender, age and body mass index (BMI), and parameters of Fibrotouch tests were collected and statistically analyzed.Results Compared to the male, female patients had significantly lower liver stiffness and fat attenuation (all P<0.001). Age, BMI and fat attenuation were positively associated with liver stiffness, with Spearman’s correlation coefficient as 0.301, 0.187 and 0.107, respectively (all P<0.001). Additionally, age and BMI were statistically positively related with fat attenuation, with Spearman’s correlation coefficient as 0.121 and 0.695, respectively (all P<0.001).Conclusion Age, gender and BMI were associated with Fibrotouch results, which might help Fibrotouch in diagnosis of chronic liver diseases.

Key words: Chronic liver diseases, Fibrotouch, Body mass index, Age, Gender, Epidemiology analysis

叶佩燕, 陆云飞, 陈晓蓉, 杨宗国. 慢性肝病患者Fibrotouch检测与人口学特征关系的流行病学分析[J]. 肝脏, 2016, 21(7): 539-541.

YE Pei-yan, LU Yun-fei, CHEN Xiao-rong, YANG Zong-guo. Epidemiology analysis of relationship between Fibrotouch tests and demographic features in chronic hepatopathy patients[J]. Chinese Hepatolgy, 2016, 21(7): 539-541.

参考文献

[1] Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol,2007, 102:2589-2600.
[2] Scott DR, Levy MT. Liver transient elastography (Fibroscan):a place in the management algorithms of chronic viral hepatitis. Antivir Ther,2010, 15:1-11.
[3] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2010年版). 肝脏,2011, 16:2-16.
[4] 陈容容,林志辉. 瞬时弹性成像技术(FibroTouch)定量评价非酒精性脂肪肝的临床研究. 福州:福建医科大学,2014:9-10.
[5] National Clinical Guideline Centre (UK). Obesity: Identification, Assessment and Management of Overweight and Obesity in Children, Young People and Adults: Partial Update of CG43. London: National Institute for Health and Care Excellence (UK),2014,National Institute for Health and Clinical Excellence: Guidance .
[6] 肝脏硬度评估小组. 瞬时弹性成像技术诊断肝纤维化专家意见. 中华肝脏病杂志,2013, 21:420-424.
[7] 王荣琦,任伟光,赵素贤,等. 瞬时弹性成像技术与多参数模型评估慢性肝病肝纤维化程度的临床研究. 中华肝脏病杂志,2015, 23:265-269.
[8] Das K, Sarkar R, Ahmed SM, et al. "Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country. Hepatology,2012,55:584-593.
[9] Sasso M, Tengher-Barna I, Ziol M, et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(R): validation in chronic hepatitis C. J Viral Hepat,2012,19:244-253.
[10] 陈学兵,朱霞,陈立宇,等.丙氨酸转氨酶对FibroScan诊断慢性乙型肝炎肝纤维化分期的影响. 中华肝脏病杂志,2011, 19:286-290.
[11] 朱梦飞,刘静,王洁,等. FibroTouch 及 FibroScan R实施受控衰减参数评价肝细胞脂肪变与肝脏病理比较分析. 中国实用内科杂志,2014, 34:589-593.
[12] Sasso M, Beaugrand M, de Ledinghen V, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol,2010,36:1825-1835.
[13] 沈峰,徐正婕,潘勤,等.FibroScan R实施受控衰减参数评价脂肪肝的影响因素及重复性分析. 实用肝脏病杂志,2013,16:59-62.